Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,032,214
+$2,290,174 QoQ
Shares Held
88,519
+93.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#554
of 2,948 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Meridiem Capital Partners LP holds $181,543,188 across 6 Medical Devices names. ABT ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
858,921 | $77,697,993 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
638,555 | $54,973,199 | |
| 3 | MDT |
Medtronic plc
|
431,042 | $33,720,415 | |
| 4 | ABT |
Abbott Laboratories
This page
|
88,519 | $8,032,214 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
298,255 | $4,500,667 | |
| 6 | PODD |
Insulet Corp
|
17,200 | $2,618,700 |
All Filings in ABT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,032,214 | 88,519 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $5,742,040 | 45,830 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,593,976 | 94,027 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $33,620,175 | 247,189 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||